2-Bromopalmitic acid (18263-25-7) inhibits protein S-palmitoylation. Blocks palmitic acid-induced increase in cAMP levels in human primary melanocytes expressing the melanocortin-1 receptor which undergoes an essential palmitoylation as a prerequisite for receptor signaling.